Biotech startups in Seoul, South Korea
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| HITS | Seoul | Series B | $13.5M | 2026-09-28 |
| Apollon | Seoul | Series A | $3.7M | 2026-09-22 |
| Standigm | Seoul | Series D | $10.0M | 2021-06-30 |
| NeoCannBio | Seoul | Series B | $7.4M | 2023-09-26 |
| Cell Lab Med | Seoul | Series B | $19.7M | 2021-11-15 |
| Avelos Therapeutics | Seoul | Series B | $12.4M | 2024-05-02 |
| Elpis Cell Therapeutics | Seoul | Series A | $3.0M | 2023-10-12 |
| InCerebro | Seoul | Seed | $4.4M | 2021-07-06 |
8 rows of the CSV in 5 of its 18 columns.
- The 121 biotech startups in Seoul, South Korea have raised $698.4M in total.
- 10 of them closed their most recent round in the last 12 months, $71.6M combined.
- The largest of those rounds is Mustbio's $23.3M Series C, dated March 2026.
- The most recent is HITS's $13.5M Series B on 28 September 2026.
- TIPS Program is an investor in 8 of them, more than any other fund.
- Health care is the most common other sector, with 105 companies (87%).
- 39% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (56% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 121| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| HITS | HITS develops artificial intelligence software for drug discovery and pharmaceutical research. | Artificial intelligence | Series B | $13.5M | 2026-09-28 | $25.1M | Korea Investment Partners, Capstone Partners, Company K Partners +2 | 11 to 50 | 2020 |
| Apollon | Apollon develops noninvasive continuous glucose monitoring systems. | Artificial intelligence | Series A | $3.7M | 2026-09-22 | $6.4M | TIPS Program, KB Investment, TheVentures +2 | 11 to 50 | 2021 |
| Ultimate Potential | Ultimate Potential is a brand offering hyper-personalized sports nutrition. | Biotech | Seed | $39K | 2023-12-26 | CNTTECH, Strong Ventures | 11 to 50 | 2020 | |
| Plcoskin | Plcoskin is a MedTech company that offers reconstructive plastic surgery and regenerative skincare. | Biotech | Series B | $4.5M | 2023-08-31 | TIPS Program, Primer, We Ventures +1 | 11 to 50 | 2018 | |
| Looxid Labs | Looxid Labs integrates emotion recognition with virtual reality using eye and brain interface technology. | Artificial intelligence | Series A | $4.0M | 2018-11-12 | TIPS Program, Samsung Ventures, Bluepoint +2 | 1 to 10 | 2015 |
Table 1. Biotech startups in Seoul, South Korea: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 121.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HITS | HITS develops artificial intelligence software for drug discovery and pharmaceutical research. | Artificial intelligence | Series B | $13.5M | 2026-09-28 | $25.1M | Korea Investment Partners, Capstone Partners, Company K Partners +2 | 11 to 50 | 2020 |
| 2 | Apollon | Apollon develops noninvasive continuous glucose monitoring systems. | Artificial intelligence | Series A | $3.7M | 2026-09-22 | $6.4M | TIPS Program, KB Investment, TheVentures +2 | 11 to 50 | 2021 |
Table 2. Biotech startups in Seoul, South Korea: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | TIPS Program | Startup incubator | Gangneung, South Korea | 8 | 7% | 1 | Apollon |
| 2 | KB Investment | Private equity firm | Seoul, South Korea | 3 | 2% | 1 | Apollon |
| 3 | STIC Ventures | Venture capital firm | Seoul, South Korea | 2 | 2% | 2 | HITS, Apollon |
| 4 | Korea Investment Partners | Private equity firm | Seoul, South Korea | 2 | 2% | 1 | HITS |
| 5 | Company K Partners | Venture capital firm | Ilsangu, South Korea | 2 | 2% | 1 | HITS |
| 6 | TheVentures | Venture capital firm | Seoul, South Korea | 2 | 2% | 1 | Apollon |
| 7 | Mirae Asset Venture Investment | Venture capital firm | Seongnam, South Korea | 2 | 2% | ||
| 8 | Kolon Investment | Private equity firm | Seoul, South Korea | 2 | 2% | ||
| 9 | UTC Investment Co. | Venture capital firm | Seoul, South Korea | 2 | 2% | ||
| 10 | Bluepoint | Startup accelerator | Daejeon, South Korea | 2 | 2% | ||
| 11 | Kiwoom Investment | Venture capital firm | Youidodong, South Korea | 1 | 1% | 1 | HITS |
| 12 | Capstone Partners | Venture capital firm | Seoul, South Korea | 1 | 1% | 1 | HITS |
| 13 | Future Science and Technology Holdings | Venture capital firm | Daejeon, South Korea | 1 | 1% | 1 | Apollon |
| 14 | Kakao Ventures | Venture capital firm | Seongnam, South Korea | 1 | 1% | ||
| 15 | Pavilion Capital Partners | Private equity firm | New York, United States | 1 | 1% |
Table 3. Biotech startups in Seoul, South Korea: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 105 | 87% | $459.1M |
| Software | 20 | 17% | $53.1M |
| Artificial intelligence | 14 | 12% | $39.3M |
| Hardware | 10 | 8% | $30.7M |
| Education | 1 | 1% | |
| Cybersecurity | 1 | 1% |
Table 4. Biotech startups in Seoul, South Korea by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in Seoul, South Korea by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 10% | |
| September 2026 | 3 | 30% | $23.1M |
| August 2026 | 1 | 10% | |
| June 2026 | 2 | 20% | $14.0M |
| March 2026 | 1 | 10% | $23.3M |
| December 2025 | 2 | 20% | $11.3M |
Table 6. Biotech startups in Seoul, South Korea: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 8 | 7% | $60.3M |
| 2025 | 10 | 8% | $72.5M |
| 2024 | 10 | 8% | $65.9M |
| 2023 | 22 | 18% | $61.1M |
| 2022 | 20 | 17% | $92.8M |
| 2021 | 24 | 20% | $302.8M |
Table 7. Biotech startups in Seoul, South Korea by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 7 | 6% |
| 2020 to 2022 | 38 | 33% |
| 2015 to 2019 | 59 | 51% |
| 2010 to 2014 | 9 | 8% |
| Before 2010 | 3 | 3% |
Table 8. Biotech startups in Seoul, South Korea by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 36 | 38% |
| 11 to 50 | 54 | 56% |
| 51 to 100 | 6 | 6% |
Table 9. Biotech startups in Seoul, South Korea by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Seoul, South Korea. On 16 November 2026 that is 121 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 121 rows: 36 have no round amount, 0 no city and 48 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Seoul, South Korea are on the list?
- 121, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 121 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.